Predictors of Arrhythmia Recurrence After Cryoballoon Ablation for Persistent Atrial Fibrillation: A Sub‐Analysis of the Cryo Global Registry
Journal of Cardiovascular Electrophysiology · 2025
DOI: 10.1111/jce.16571 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2025. Verfasst von K R Julian Chun und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cardioangiologisches Centrum Bethanien, Frankfurt, Germany. Hauptthemen laut MEDLINE: Atrial Fibrillation, Cryosurgery, Pulmonary Veins, Tachycardia, Supraventricular. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The study was supported by the Medtronic., Medtronic.
Abstract (Originalsprache)
Introduction
Freedom from recurrences of atrial tachyarrhythmia (ATA) is suboptimal after pulmonary vein isolation (PVI) in patients with persistent atrial fibrillation (PsAF). This sub‐analysis from the Cryo Global Registry sought to investigate predictors of ablation success after PVI using cryoballoon ablation (CBA) for PsAF. Methods and Results ATA recurrence was defined as ≥ 30 s recurrence of atrial fibrillation, atrial flutter or atrial tachycardia after a 90‐day blanking period and through 12‐months. Univariate and multivariable Cox regression analysis (with ATA recurrence as an endpoint) was performed to identify CBA responders. PsAF patients ( N = 882) were on average 63.9 ± 11.3 years old (69.2% male), and freedom from ATA recurrence was 79.7% (76.8%–82.2%). Longer elapsed time from PsAF diagnosis to ablation (hazard ratio [HR] 1.07 (95% confidence interval [CI]: 1.03–1.11); p = 0.002) and a larger number of previously failed antiarrhythmic drugs (HR 1.39 (95% CI: 1.13–1.70); p < 0.002) were shown to be independent predictors of ATA recurrence in a multivariate model which included 703 evaluated patients.
Conclusion
These real‐world results provide important insights to guide referral of PsAF patients, including the benefits of earlier treatment via CBA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardioangiologisches Centrum Bethanien, Frankfurt, Germany.
- Universitat Bielefeld Medizinische Fakultat OWL, Bielefeld, Germany.
- Shonan Kamakura Sogo Byoin Nosocchu Shinryoka, Kamakura, Japan.
- Sana Klinikum Lichtenberg, Berlin, Germany.
- Seoul National University Bundang Hospital, Seongnam, South Korea.
- Medtronic, Minneapolis, MN, United States.
ORCID-Profile: Kelly A van Bragt, Daniel Becker
Förderung
- The study was supported by the Medtronic.
- Medtronic
Zitieren
APA
Chun, K. R. J., Stellbrink, C., Murakami, M., Drephal, C., Oh, I. Y., van Bragt, K. A., Becker, D., Anselme, S., Todd, D., Kaczmarek, K., & Nitta, J. (2025). Predictors of Arrhythmia Recurrence After Cryoballoon Ablation for Persistent Atrial Fibrillation: A Sub‐Analysis of the Cryo Global Registry. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.16571
Vancouver
Chun KRJ, Stellbrink C, Murakami M, Drephal C, Oh IY, van Bragt KA, et al. Predictors of Arrhythmia Recurrence After Cryoballoon Ablation for Persistent Atrial Fibrillation: A Sub‐Analysis of the Cryo Global Registry. Journal of Cardiovascular Electrophysiology. 2025. doi:10.1111/jce.16571
BibTeX
@article{Chun2025,
author = {Chun, K R Julian and Stellbrink, Christoph and Murakami, Masato and Drephal, Christian and Oh, Il-Young and van Bragt, Kelly A and Becker, Daniel and Anselme, Sylvain and Todd, Derick and Kaczmarek, Krzysztof and Nitta, Junichi},
title = {Predictors of Arrhythmia Recurrence After Cryoballoon Ablation for Persistent Atrial Fibrillation: A Sub‐Analysis of the Cryo Global Registry},
journal = {Journal of Cardiovascular Electrophysiology},
year = {2025},
doi = {10.1111/jce.16571}
}
EUVIMED